Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bühler is a Swiss multinational technology company that provides advanced process solutions and equipment for the food, mobility, and life sciences industries. In the pharmaceutical sector, the company specializes in wet grinding, dispersing, and extrusion technologies used for the production of active pharmaceutical ingredients (APIs) and advanced drug delivery systems. Bühler is a key player in the biotechnology space through its innovative platforms for sustainable protein production, including plant-based meat alternatives and insect processing. The company operates globally in over 140 countries, focusing on engineering solutions that integrate sustainability with high-efficiency manufacturing. Its pharmaceutical applications specifically address challenges in bioavailability and the formulation of poorly soluble drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bühler.